Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
NCT ID: NCT05763940
Last Updated: 2024-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
130 participants
INTERVENTIONAL
2022-05-25
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Omega-3 Supplement and Health Markers
NCT06492694
A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA
NCT06629103
A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo
NCT07241377
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
NCT00344721
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OmegaBoost (QD)
Participants assigned the study supplement OmegaBoost, taken once daily (QD).
OmegaBoost
An ultra-pure omega-3 fish oil supplement with no fishy aftertaste and no fish burps.
10x more omega-3 from fish oil than the leading omega-3 gummies. Gel bites have better absorption than ordinary, hard-to-swallow fish oil pills.
OmegaBoost (BID)
Participants assigned the study supplement OmegaBoost, taken twice daily (BID).
OmegaBoost
An ultra-pure omega-3 fish oil supplement with no fishy aftertaste and no fish burps.
10x more omega-3 from fish oil than the leading omega-3 gummies. Gel bites have better absorption than ordinary, hard-to-swallow fish oil pills.
Nature Made (soft gel)
Participants assigned the Nature Made (soft gel), taken twice daily.
Nature Made (soft gel)
A commercially-available omega-3 soft gel formula
Nature Made (gummy)
Participants assigned the Nature Made (gummy), taken twice daily.
Nature Made (gummy)
A commercially-available omega-3 formula in gummy form
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OmegaBoost
An ultra-pure omega-3 fish oil supplement with no fishy aftertaste and no fish burps.
10x more omega-3 from fish oil than the leading omega-3 gummies. Gel bites have better absorption than ordinary, hard-to-swallow fish oil pills.
Nature Made (soft gel)
A commercially-available omega-3 soft gel formula
Nature Made (gummy)
A commercially-available omega-3 formula in gummy form
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to swallow softgel or chew gummies nutritional supplement daily for a 12 week period
* able to make four (4) follow-up visits
Exclusion Criteria
* h/o Atrial fibrillation, or at risk of Afib
* h/o congestive heart failure, heart disease, or prior myocardial infarction and/or cerebrovascular accident
* noncompliance with study requirements
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guardion Health Sciences, Inc.
INDUSTRY
Western University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pinakin Davey
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pinakin Gunvant Davey, PhD, OD
Role: PRINCIPAL_INVESTIGATOR
Western University of Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western University of Health Sciences
Pomona, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GHS.002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.